Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEMETIS, INC Director's Dealing 2012

Sep 19, 2012

33927_dirs_2012-09-19_73d2a5c9-2d7b-49c5-ae15-36e5e7824e33.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AEMETIS, INC (AMTX)
CIK: 0000738214
Period of Report: 2008-01-29

Reporting Person: CAGAN LAIRD Q (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-11-26 Common Stock X 358581 $1.5 Acquired 358581 Direct
2008-12-01 Common Stock X 99488 $3 Acquired 458069 Direct
2008-11-17 Common Stock J 12000000 Disposed 0 Indirect
2008-11-17 Common Stock J 6000000 Acquired 12907000 Indirect
2010-05-11 Common Stock J 600000 Acquired 1058069 Direct
2011-07-06 Common Stock G 200000 Disposed 12707000 Indirect
2011-07-06 Common Stock G 2000000 Disposed 10707000 Indirect
2011-07-06 Common Stock G 2000000 Acquired 2000000 Indirect
2011-10-06 Common Stock J 7659760 $0.05 Acquired 18366760 Indirect
2011-12-22 Common Stock G 147000 Disposed 911069 Direct
2012-02-08 Common Stock G 100000 Disposed 811069 Direct
2012-06-21 Common Stock X 36667 $0.001 Acquired 847736 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-01-29 Common Stock Warrant $1.5 G 175000 Disposed 2013-04-25 Common Stock (175000) Direct
2008-11-26 Common Stock Warrant $1.5 X 526666 Disposed 2013-04-25 Common Stock (526666) Direct
2008-12-01 Series B Warrant $3 X 275055 Disposed 2011-09-05 Common Stock (275055) Direct
2012-06-14 Common Stock Warrant $0.001 X 36667 Acquired 2017-06-14 Common Stock (36667) Direct
2012-06-21 Common Stock Warrant $0.001 X 36667 Disposed 2017-06-14 Common Stock (36667) Direct

Footnotes

F1: The reporting person affected a cashless exercise of the Common Stock Warrant surrendering 168,085 warrant shares valued at $4.70 per share and was issued a net of 358,581 shares.

F2: The reporting person affected a cashless exercise of the Series B Warrant surrendering 175,567 warrant shares valued at $4.70 per share and was issued a net of 99,488 shares.

F3: Transfer of shares to limited liability company members, including 6,000,000 shares to Cagan Capital, LLC, which is indirectly beneficially owned by the Reporting Person.

F4: Issued in consideration for services rendered to the Issuer.

F5: Note conversion at $0.05 per share.

F6: Fully exercisable upon issuance.

F7: Multiple expiration dates from 9/5/11 through 9/21/12.